These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 33441861)
1. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA). Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063 [TBL] [Abstract][Full Text] [Related]
3. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044 [TBL] [Abstract][Full Text] [Related]
4. Antibodies Elicited by the Micoli F; Rossi O; Conti V; Launay O; Sciré AS; Aruta MG; Nakakana UN; Marchetti E; Rappuoli R; Saul A; Martin LB; Necchi F; Podda A Front Immunol; 2021; 12():671325. PubMed ID: 34017343 [No Abstract] [Full Text] [Related]
5. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations. Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581 [TBL] [Abstract][Full Text] [Related]
6. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach. Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338 [TBL] [Abstract][Full Text] [Related]
7. Complement-mediated serum bactericidal activity of antibodies elicited by the Kapulu MC; Nakakana U; Sciré AS; Sarakinou E; Conti V; Rossi O; Acquaviva A; Necchi F; Obiero CW; Martin LB; Bejon P; Njuguna P; Micoli F; Podda A Front Immunol; 2022; 13():971866. PubMed ID: 36203568 [No Abstract] [Full Text] [Related]
8. Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Gasperini G; Raso MM; Arato V; Aruta MG; Cescutti P; Necchi F; Micoli F Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525644 [TBL] [Abstract][Full Text] [Related]
9. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965 [TBL] [Abstract][Full Text] [Related]
10. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes. Citiulo F; Necchi F; Mancini F; Rossi O; Aruta MG; Gasperini G; Alfini R; Rondini S; Micoli F; Rappuoli R; Saul A; Martin LB PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009826. PubMed ID: 34644291 [TBL] [Abstract][Full Text] [Related]